TACTIC: Phase 2 trial of panitumumab, cisplatin and gemcitabine in biliary tract cancer The TACTIC trial is helping researchers answer an important health question. It is providing evidence on whether panitumumab (Vectib

Source URL: www.ctc.usyd.edu.au

AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC

Source URL: www.ctueoc.ch

ICECREAM: Cetuximab antibody treatment for colorectal cancer with a G13D gene mutation The ICECREAM trial has helped researchers answer an important health question. It has provided evidence that cetuximab alone is not a

Source URL: www.ctc.usyd.edu.au

• Bristol-Myers Squibb
• Cetuximab
• Eli Lilly and Company
• Cancer treatments
• Chemotherapy
• KRAS
• Colorectal cancer
• Abituzumab
• Panitumumab

PAN01 biomarker poster ESMO 15.pdf

Source URL: www.ctueoc.ch

• Bristol-Myers Squibb
• Cetuximab
• Eli Lilly and Company
• Epidermal growth factor receptor
• WT
• Panitumumab
• Biomarker
• KRAS
• Head and neck cancer

ATTAX3: Panitumumab added to docetaxel, cisplatin, fluoropyrimidine in oesophagogastric cancer The ATTAX3 trial has helped researchers answer an important health question. It has provided evidence on the value of a new c

Source URL: www.ctc.usyd.edu.au

• Panitumumab
• Amgen
• Chemotherapy
• Docetaxel
• Stomach cancer
• Oncology
• Cetuximab

Award ID: DP150074 Project Title: Inhibitors of Hydrogen Sulfide Biosynthesis: Preclinical Development of Novel Colorectal Cancer Therapies Award Mechanism:

Source URL: www.cprit.state.tx.us

• Bristol-Myers Squibb
• Cetuximab
• Colorectal cancer
• KRAS
• BRAF
• Cancer
• Epidermal growth factor receptor
• Panitumumab
• Selumetinib
• Medicine
• Oncogenes
• Oncology

7.5 PANITUMUMAB, injection, 100 mg/5 mL and 400 mg/20 mL, Vectibix®, Amgen Australia Pty Ltd. Purpose of Application To request that the current Section 100 (Efficient Funding of Chemotherapy Program) Authority Require

Source URL: www.pbs.gov.au

• Bristol-Myers Squibb
• Cetuximab
• Panitumumab
• KRAS
• Bevacizumab
• Immune system
• Oxaliplatin
• Colorectal cancer
• FOLFOX
• Medicine
• Chemistry
• Pharmacology

DOCX Document

Source URL: www.pbs.gov.au

• Pharmacology
• Bristol-Myers Squibb
• Cetuximab
• Bevacizumab
• Pfizer
• Panitumumab
• FOLFIRI
• KRAS
• Colorectal cancer
• Medicine
• Chemistry
• Chemotherapy regimens

固形がん いずれも国内で承認された効能・効果／用法・用量に限るものとする。 • – KRAS/NRAS遺伝子野生型の治癒切除不能な進行・

Source URL: www.takeda.co.jp

Vectibix PI Appendix 2 (PI)

Source URL: www.ema.europa.eu

• Colorectal cancer
• Panitumumab
• KRAS
• Oxaliplatin
• FOLFOX
• Chemotherapy
• Cetuximab
• Medicine
• Chemistry
• Bevacizumab